000 01570 a2200397 4500
005 20250515180137.0
264 0 _c20090928
008 200909s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-08-2277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElliott, Christopher S
245 0 0 _aThe influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cJul 2009
300 _a4694-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aBiopsy
_xmethods
650 0 4 _aDiagnosis, Differential
650 0 4 _aEnzyme Inhibitors
_xtherapeutic use
650 0 4 _aFinasteride
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOutcome Assessment, Health Care
_xmethods
650 0 4 _aPredictive Value of Tests
650 0 4 _aProstate
_xdrug effects
650 0 4 _aProstate-Specific Antigen
_xanalysis
650 0 4 _aProstatic Neoplasms
_xmetabolism
650 0 4 _aRetrospective Studies
700 1 _aShinghal, Rajesh
700 1 _aPresti, Joseph C
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 15
_gno. 14
_gp. 4694-9
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-08-2277
_zAvailable from publisher's website
999 _c18999537
_d18999537